U.S. Markets closed

Biotech News: Why Advaxis Stock Is Soaring Today

William White
Biotech News: Why Advaxis Stock Is Soaring Today

Advaxis stock is flying high Monday on news concerning a Phase1/2 study of ADXS-PSA.Source: Shutterstock ADXS-PSA is Advaxis' (NASDAQ:ADXS) Listeria monocytogenes-based immunotherapies. The drug is being evaluated for use on its own, as well as with Merck's (NYSE:MRK) anti-PD-1 therapy.The study